MwanzoBIOCON • NSE
add
Biocon Ltd
Bei iliyotangulia
₹ 360.25
Bei za siku
₹ 358.15 - ₹ 368.00
Bei za mwaka
₹ 291.00 - ₹ 406.00
Thamani ya kampuni katika soko
479.24B INR
Wastani wa hisa zilizouzwa
4.75M
Uwiano wa bei na mapato
111.87
Mgao wa faida
0.14%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 39.42B | 14.83% |
Matumizi ya uendeshaji wa biashara | 22.43B | 10.21% |
Mapato halisi | 314.00M | -95.24% |
Kiwango cha faida halisi | 0.80 | -95.84% |
Mapato kwa kila hisa | 0.26 | -95.10% |
EBITDA | 6.89B | 15.70% |
Asilimia ya kodi ya mapato | 7.95% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 45.65B | 77.35% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 277.12B | — |
hisa zilizosalia | 1.21B | — |
Uwiano wa bei na thamani | 1.99 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 1.59% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 314.00M | -95.24% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1978
Makao Makuu
Tovuti
Wafanyakazi
3,442
